Press Releases Medicare Could Save $14 Billion with Access to Ozempic and Wegovy Generics September 24, 2024
Letters, Testimony & Filings Testimony Before the FDA’s Antimicrobial Drugs Advisory Committee Meeting about Sulopenem Etzadroxil/Probenecid for Uncomplicated Urinary Tract Infection September 9, 2024
Letters, Testimony & Filings Stakeholder comment to Reagan-Udall/FDA meeting regarding the treatment for PTSD September 6, 2024
Press Releases First round of Medicare Drug Price Negotiations Promising Steps against Pharma Profiteering August 14, 2024
Press Releases FDA was Right to Decline Approval of MDMA-Assisted Therapy for PTSD and Encourage Further Research August 9, 2024
Press Releases Novo Nordisk’s $50 billion in Ozempic & Wegovy Sales Comes at the Expense of Healthcare Solvency August 7, 2024
Press Releases Public Citizen Urges HHS to Unlock Generic Competition for Popular Weight Loss Drugs Ozempic and Wegovy August 5, 2024